Therapeutic Strategies for Mitochondrial Dysfunction and Oxidative Stress in Age-Related Metabolic Disorders

被引:46
作者
Bhatti, J. S. [1 ,2 ]
Kumar, S. [1 ]
Vijayan, M. [1 ]
Bhatti, G. K. [3 ]
Reddy, P. H. [1 ,4 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Garrison Inst Aging, Lubbock, TX 79430 USA
[2] Sri Guru Gobind Singh Coll, Dept Biotechnol, Chandigarh, India
[3] Panjab Univ, UGC Ctr Excellence Nano Applicat, Chandigarh, India
[4] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA
来源
MOLECULAR BIOLOGY OF AGING | 2017年 / 146卷
关键词
TUMOR-NECROSIS-FACTOR; OXYGEN-FREE-RADICALS; EXACERBATES CEREBRAL INFARCTION; ALZHEIMERS-DISEASE IMPLICATIONS; SKELETAL-MUSCLE MITOCHONDRIA; ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; TARGETED ANTIOXIDANT; RISK-FACTORS; CARDIOVASCULAR-DISEASE;
D O I
10.1016/bs.pmbts.2016.12.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondria are complex, intercellular organelles present in the cells and are involved in multiple roles including ATP formation, free radicals generation and scavenging, calcium homeostasis, cellular differentiation, and cell death. Many studies depicted the involvement of mitochondrial dysfunction and oxidative damage in aging and pathogenesis of age-related metabolic disorders and neurodegenerative diseases. Remarkable advancements have been made in understanding the structure, function, and physiology of mitochondria in metabolic disorders such as diabetes, obesity, cardiovascular diseases, and stroke. Further, much progress has been done in the improvement of therapeutic strategies, including lifestyle interventions, pharmacological, and mitochondria-targeted therapeutic approaches. These strategies were mainly focused to reduce the mitochondrial dysfunction caused by oxidative stress and to retain the mitochondrial health in various diseases. In this chapter, we have highlighted the involvement of mitochondrial dysfunction in the pathophysiology of various disorders and recent progress in the development of mitochondria-targeted molecules as therapeutic measures for metabolic disorders.
引用
收藏
页码:13 / 46
页数:34
相关论文
共 258 条
[1]   Mitochondrial Dysfunction, Insulin Resistance, and Type 2 Diabetes Mellitus [J].
Abdul-Ghani, Muhammad A. ;
DeFronzo, Ralph A. .
CURRENT DIABETES REPORTS, 2008, 8 (03) :173-178
[2]   Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation [J].
Abramov, Andrey Y. ;
Scorziello, Antonella ;
Duchen, Michael R. .
JOURNAL OF NEUROSCIENCE, 2007, 27 (05) :1129-1138
[3]   Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury [J].
Adlam, VJ ;
Harrison, JC ;
Porteous, CM ;
James, AM ;
Smith, RAJ ;
Murphy, MP ;
Sammut, IA .
FASEB JOURNAL, 2005, 19 (09) :1088-1095
[4]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[5]  
2-S
[6]   A Perspective on Sirtuins in the Metabolic Syndrome [J].
Albiero, Mattia ;
Avogaro, Angelo ;
Fadini, Gian Paolo .
METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (04) :161-164
[7]   Caloric Restriction and Aging: Studies in Mice and Monkeys [J].
Anderson, Rozalyn M. ;
Shanmuganayagam, Dhanansayan ;
Weindruch, Richard .
TOXICOLOGIC PATHOLOGY, 2009, 37 (01) :47-51
[8]   Mitochondrial metabolism of reactive oxygen species [J].
Andreyev, AI ;
Kushnareva, YE ;
Starkov, AA .
BIOCHEMISTRY-MOSCOW, 2005, 70 (02) :200-214
[9]  
[Anonymous], CONS WORLDW DEF MET
[10]   Mitochondrial Dynamics - Mitochondrial Fission and Fusion in Human Diseases [J].
Archer, Stephen L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (23) :2236-2251